-
1دورية أكاديمية
المؤلفون: Roberts, Morgan E.1 (AUTHOR) morganeroberts@health.southalabama.edu, Vines, Katie1 (AUTHOR), Sullivan, Frances G.2 (AUTHOR), Phung, Thuy2,3 (AUTHOR), Liles, Joe S.1,2 (AUTHOR), Howard, John H.1,2 (AUTHOR)
المصدر: American Surgeon. Jun2024, Vol. 90 Issue 6, p1809-1812. 4p.
مصطلحات موضوعية: *IPILIMUMAB, *PATHOLOGIC complete response, *CLINICAL trials, *TYPE 1 diabetes, *MELANOMA
-
2دورية أكاديمية
المؤلفون: Konishi, Kota1 (AUTHOR), Okamoto, Mamiko1 (AUTHOR), Tokumitsu, Ryuichi1 (AUTHOR), Yano, Mitsutake1 (AUTHOR) yano1210@oita-u.ac.jp, Nasu, Kaei1,2 (AUTHOR), Kobayashi, Eiji1 (AUTHOR)
المصدر: Medical Molecular Morphology. Jun2024, Vol. 57 Issue 2, p83-90. 8p.
مصطلحات موضوعية: *IPILIMUMAB, *MELANOMA, *DRUG side effects, *IMMUNE checkpoint inhibitors, *NIVOLUMAB, *PROGRAMMED death-ligand 1, *CESAREAN section
-
3دورية أكاديمية
المؤلفون: Jazieh, Khalid1 kjazieh@gmail.com, Kottschade, Lisa1, Dimou, Anastasios1
المصدر: Journal of Immunotherapy & Precision Oncology. May2024, Vol. 7 Issue 2, p126-129. 4p.
مصطلحات موضوعية: *IPILIMUMAB, *METASTASIS, *IMMUNE checkpoint inhibitors, *BLEPHAROPTOSIS, *TOXICITY testing
-
4دورية أكاديمية
المؤلفون: Van Not, Olivier J.1,2 (AUTHOR), van den Eertwegh, Alfons J. M.3 (AUTHOR), Haanen, John B.4 (AUTHOR), van Rijn, Rozemarijn S.5 (AUTHOR), Aarts, Maureen J. B.6 (AUTHOR), van den Berkmortel, Franchette W. P. J.7 (AUTHOR), Blank, Christian U.4,8 (AUTHOR), Boers‐Sonderen, Marye J.9 (AUTHOR), de Groot, Jan Willem W. B.10 (AUTHOR), Hospers, Geke A. P.11 (AUTHOR), Kapiteijn, Ellen12 (AUTHOR), Bloem, Manja1,13,14 (AUTHOR), Piersma, Djura15 (AUTHOR), Stevense‐den Boer, Marion16 (AUTHOR), Verheijden, Rik J.2 (AUTHOR), van der Veldt, Astrid A. M.17 (AUTHOR), Wouters, Michel W. J. M.1,13,14 (AUTHOR), Blokx, Willeke A. M.18 (AUTHOR), Suijkerbuijk, Karijn P. M.2 (AUTHOR) k.suijkerbuijk@umcutrecht.nl
المصدر: Cancer (0008543X). May2024, Vol. 130 Issue 9, p1673-1683. 11p.
مصطلحات موضوعية: *IPILIMUMAB, *PROPORTIONAL hazards models, *BRAF genes, *MELANOMA, *LACTATE dehydrogenase
-
5دورية أكاديمية
المؤلفون: Mukhtar, Abdullahi B1 (AUTHOR), Morgan, Huw J1 (AUTHOR), Gibbs, Alex1 (AUTHOR), Davies, Gemma E1 (AUTHOR), Lovatt, Charlotte1 (AUTHOR), Patel, Girish K1 (AUTHOR) patelgk@cardiff.ac.uk
المصدر: British Journal of Dermatology. May2024, Vol. 190 Issue 5, p729-739. 11p.
مصطلحات موضوعية: *IPILIMUMAB, *CANCER cells, *MELANOMA, *BRAF genes, *STEM cell treatment, *FORKHEAD transcription factors
-
6دورية أكاديمية
المؤلفون: Mao, Yun‐tao1 (AUTHOR), Wang, Ying1,2 (AUTHOR), Chen, Xiao‐Xiao1 (AUTHOR), Liu, Cheng‐jiang3 (AUTHOR), Bao, Qi4 (AUTHOR) baoqi@zju.edu.cn
المصدر: Journal of Cosmetic Dermatology. Apr2024, Vol. 23 Issue 4, p1165-1177. 13p.
مصطلحات موضوعية: *IPILIMUMAB, *IMMUNE checkpoint inhibitors, *DRUG side effects, *CLINICAL trials, *NIVOLUMAB, *MELANOMA
-
7دورية أكاديمية
المؤلفون: Parra, Edwin, Zhang, Jiexin, Duose, Dzifa, Gonzalez-Kozlova, Edgar, Redman, Mary, Chen, Hong, Manyam, Ganiraju, Kumar, Gayatri, Zhang, Jianhua, Song, Xingzhi, Lazcano, Rossana, Marques-Piubelli, Mario, Laberiano-Fernandez, Caddie, Rojas, Frank, Zhang, Baili, Taing, Len, Jhaveri, Aashna, Geisberg, Jacob, Altreuter, Jennifer, Michor, Franziska, Provencher, James, Yu, Joyce, Cerami, Ethan, Moravec, Radim, Kannan, Kasthuri, Luthra, Rajyalakshmi, Alatrash, Gheath, Huang, Hsin-Hui, Xie, Hui, Patel, Manishkumar, Nie, Kai, Harris, Jocelyn, Argueta, Kimberly, Lindsay, James, Biswas, Roshni, Van Nostrand, Stephen, Kim-Schulze, Seunghee, Gray, Jhanelle, Herbst, Roy, Wistuba, Ignacio, Gettinger, Scott, Kelly, Karen, Gnjatic, Sacha, Lee, J, Zhang, Jianjun, Haymaker, Cara, Bazhenova, Lyudmila
المصدر: Clinical Cancer Research. 30(8)
مصطلحات موضوعية: Humans, Nivolumab, Lung Neoplasms, Multiomics, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Immunotherapy, Lung, Epithelial Cells, Ipilimumab, Tumor Microenvironment
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/09f8d5zrTest
-
8دورية أكاديمية
المؤلفون: Montemagno, Christopher1 (AUTHOR), Jacquel, Arnaud2 (AUTHOR), Pandiani, Charlotte3 (AUTHOR), Rastoin, Olivia4 (AUTHOR), Dawaliby, Rosie5 (AUTHOR), Schmitt, Thomas2 (AUTHOR), Bourgoin, Maxence2 (AUTHOR), Palenzuela, Héliciane5 (AUTHOR), Rossi, Anne-Laure3 (AUTHOR), Ambrosetti, Damien6 (AUTHOR), Durivault, Jerome1 (AUTHOR), Luciano, Frederic3 (AUTHOR), Borchiellini, Delphine7 (AUTHOR), Le Du, Julie4 (AUTHOR), Gonçalves, Leticia Christina Pires4 (AUTHOR), Auberger, Patrick2 (AUTHOR), Benhida, Rachid4,8 (AUTHOR), Kinget, Lisa9,10 (AUTHOR), Beuselinck, Benoit9,10 (AUTHOR), Ronco, Cyril4,8,11 (AUTHOR)
المصدر: Journal of Experimental & Clinical Cancer Research (17569966). 3/19/2024, Vol. 43 Issue 1, p1-19. 19p.
مصطلحات موضوعية: *RENAL cell carcinoma, *IPILIMUMAB, *KILLER cells, *IMMUNOTHERAPY, *T cells, *OVERALL survival
-
9دورية أكاديمية
المؤلفون: Cavillon, Ana1 (AUTHOR), Pouessel, Damien2 (AUTHOR), Houédé, Nadine3 (AUTHOR), Mathevet, Fanny1 (AUTHOR), Dauxois, Jean Yves4 (AUTHOR), Chevreau, Christine2 (AUTHOR), Culine, Stéphane5,6 (AUTHOR), Delord, Jean-Pierre2 (AUTHOR), Porcher, Raphael7,8 (AUTHOR), Filleron, Thomas1 (AUTHOR) Filleron.thomas@iuct-oncopole.fr
المصدر: European Urology. Mar2024, Vol. 85 Issue 3, p293-300. 8p.
مصطلحات موضوعية: *IPILIMUMAB, *IMMUNE checkpoint inhibitors, *CLINICAL trials, *RENAL cell carcinoma, *SURVIVAL analysis (Biometry), *PROGRESSION-free survival
-
10دورية أكاديمية
المؤلفون: Eroglu, Zeynep1,2 (AUTHOR) zeynep.eroglu@moffitt.org, Chen, Y. Ann3 (AUTHOR), Smalley, Inna4 (AUTHOR), Li, Jiannong3 (AUTHOR), Markowitz, Joseph K.1,2 (AUTHOR), Brohl, Andrew S.1,2 (AUTHOR), Tetteh, Leticia1 (AUTHOR), Taylor, Hayley1 (AUTHOR), Sondak, Vernon K.1,2 (AUTHOR), Khushalani, Nikhil I.1,2 (AUTHOR), Smalley, Keiran S. M.1,5 (AUTHOR)
المصدر: Cancer (0008543X). Jan2024, Vol. 130 Issue 2, p232-243. 12p.
مصطلحات موضوعية: *IPILIMUMAB, *MELANOMA, *BRAF genes, *PROGRESSION-free survival, *ACUTE kidney failure, *SURVIVAL rate, *VEMURAFENIB